Trial Profile
A case-controlled study to evaluate link between HER2 polymorphism and trastuzumab cardiac toxicity in patients with HER2 positive breast cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 Dec 2014
Price :
$35
*
At a glance
- Drugs Trastuzumab (Primary)
- Indications Breast cancer
- Focus Adverse reactions
- 30 Dec 2014 New trial record